Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

23. Februar 2011 10:30 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Webcast of Presentations at Upcoming Investment Conferences

CAMBRIDGE, Mass., Feb. 23, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
10. Februar 2011 08:00 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year End 2010

CAMBRIDGE, Mass., Feb. 10, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
09. Februar 2011 08:30 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Present at the 13th Annual BIO CEO Investor Conference

CAMBRIDGE, Mass., Feb. 9, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
09. Februar 2011 08:30 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Present at the Leerink Swann Hot Topics Roundtable Conference

CAMBRIDGE, Mass., Feb. 9, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
08. Februar 2011 16:05 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Awarded U.S. Patent for Methods of Preparing Glatiramer Acetate

CAMBRIDGE, Mass., Feb. 8, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, announced...
27. Januar 2011 16:45 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Fourth Quarter and Year End 2010 Financial Results

CAMBRIDGE, Mass., Jan. 27, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
19. Januar 2011 14:45 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Appointment of Thomas P. Koestler to Board of Directors

CAMBRIDGE, Mass., Jan. 19, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs,...
04. Januar 2011 09:00 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Appoints Young T. Kwon as Vice President, Business Development

CAMBRIDGE, Mass., Jan. 4, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
22. Dezember 2010 16:05 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Exercise and Closing of Over-Allotment Option

CAMBRIDGE, Mass., Dec. 22, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
13. Dezember 2010 11:36 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Completion of Public Offering of Common Stock

CAMBRIDGE, Mass., Dec. 13, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...

Vorherige Seite

Nächste Seite